Icon plc diskutieren
Icon plc
WKN: 932242 / Symbol: ICLR / Name: ICON / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
149,70 €
0,03 %
ICON Public Limited (NASDAQ: ICLR) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $263.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $263.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at JPMorgan Chase & Co. from $280.00 to $265.00. They now have an "overweight" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Truist Financial Co. from $284.00 to $262.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Barclays PLC from $275.00 to $240.00. They now have an "overweight" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Citigroup Inc. from $290.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Mizuho from $238.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Mizuho from $200.00 to $173.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Evercore ISI from $155.00 to $170.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $224.00 price target on the stock, up previously from $150.00.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Evercore ISI from $170.00 to $240.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Truist Financial Corporation from $187.00 to $234.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at UBS Group AG from $170.00 to $240.00. They now have a "buy" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) had its price target raised by analysts at Mizuho from $173.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Ratings data for ICLR provided by MarketBeat
Icon (ICLR) was upgraded by BMO Capital Markets from "market perform" to "outperform". They now have a $130.00 price target on the stock, up from $100.00.
Ratings data for ICLR provided by MarketBeat
Icon (ICLR) had its "underperform" rating reaffirmed by Bank of America Corporation.
Ratings data for ICLR provided by MarketBeat
Neueste Beiträge
Mizuho in Advanced Micro Devices Inc. diskutieren